PT Takeda Indonesia (Indonesia)

Takeda Indonesia is primarily engaged in pharmaceutical preparations activity. Its headquarters is located in Dki Jakarta. The company was founded in 1971. Takeda Indonesia is a subsidiary of Takeda Pharmaceutical Company Limited, a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan. The company was founded by Chobei Takeda I in 1781 and has since grown to become one of the largest pharmaceutical companies in the world. In Indonesia, Takeda focuses on providing innovative medicines in several therapeutic areas, including oncology, gastroenterology, rare diseases, and vaccines. The company is committed to improving patient outcomes and enhancing the quality of life for people in Indonesia through its high-quality pharmaceutical products. Takeda Indonesia operates several branches across the country, ensuring a strong local presence and accessibility to its products. The company is also involved in various community health initiatives and partnerships with local healthcare providers to support public health and education. Globally, Takeda operates in over 80 countries, with a significant presence in Asia, Europe, and the Americas. The company is known for its strong pipeline of innovative drugs and its commitment to research and development, investing heavily in cutting-edge technologies and collaborations with research institutions worldwide. Takeda Indonesia is a member of several pharmaceutical and healthcare associations, actively participating in industry discussions and contributing to the development of healthcare policies in the region. The company's mission is to strive towards better health and a brighter future for people worldwide through leading innovation in medicine.